Could a home device spot heart trouble in childhood cancer survivors?
NCT ID NCT05138991
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a portable, self-administered device that measures heart function in childhood cancer survivors, who are at risk for heart problems from past treatments. Researchers will compare the device's accuracy and ease of use in the clinic and at home against standard hospital tests like echocardiograms and MRIs. The goal is to see if this simpler approach can detect early signs of heart trouble effectively.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SphygmoCor® Xcel and Oscar 2™ ambulatory blood pressure monitor
What this could lead to
If successful, this portable system could allow childhood cancer survivors to easily monitor their heart health at home, catching problems earlier than current methods.
What could go wrong
This is an early-stage study focused on accuracy and reproducibility, not treatment. The device may not prove reliable enough to replace standard hospital tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States